Heath A Elrod Selected Research

Lung Neoplasms (Lung Cancer)

9/2009	Celecoxib antagonizes perifosine's anticancer activity involving a cyclooxygenase-2-dependent mechanism.
7/2007	The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Heath A Elrod Research Topics

Disease

5	Neoplasms (Cancer) 08/2010 - 07/2007
2	Squamous Cell Carcinoma of Head and Neck 12/2010 - 08/2010
2	Lung Neoplasms (Lung Cancer) 09/2009 - 07/2007
1	Neoplasm Metastasis (Metastasis) 08/2010
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2009
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2007

Drug/Important Bio-Agent (IBA)

3	perifosineIBA 12/2010 - 07/2007
2	LigandsIBA 02/2008 - 01/2008
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 08/2010
1	Proteins (Proteins, Gene)FDA Link 08/2010
1	Caspase 8 (Caspase-8)IBA 08/2010
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2009
1	Celecoxib (Celebrex)FDA Link 09/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2008
1	Death Domain ReceptorsIBA 02/2008
1	ProstaglandinsIBA 01/2008
1	Antineoplastic Agents (Antineoplastics)IBA 01/2008
1	ThiazolidinedionesIBA 01/2008
1	PPAR gammaIBA 01/2008

Therapy/Procedure

2	Therapeutics 02/2008 - 01/2008
1	Chemoprevention 01/2008